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High-level polyomavirus BK (BKPyV) replication in urothelial cells is a hallmark of polyomavirus-
associated hemorrhagic cystitis (PyVHC), a painful condition affecting bone marrow transplant
recipients. In kidney transplant recipients, replication in tubular epithelial cells is associated with
overt disease whereas high-level urothelial replication is clinically silent. We characterized BKPyV
replication in primary human urothelial cells (HUCs) and compared it to replication in renal tubular
epithelial cells (RPTECs). HUCs were easily infected, as shown by expression of T-antigens, VP1-3, and
agnoprotein, and intranuclear virion production. Compared to RPTECs, progeny release was delayed by
Z24 h and reduced. BKPyV-infected HUCs rounded up like ‘‘decoy cells’’ and detached without necrosis
as shown by delayed cytokeratin-18 release, real-time viability monitoring and imaging. The data show
that BKV infection of HUCs and RPTECs is signiﬁcantly different and support the notion that PyVHC
pathogenesis is not solely due to BKPyV replication, but likely requires urotoxic and immunological
cofactors.
& 2013 Elsevier Inc. All rights reserved.Introduction
The human polyomavirus BK (BKPyV) was ﬁrst isolated from the
urine of a renal transplant patient with ureteric stenosis, shedding
cytopathically altered cells with atypical nuclear morphology
(Gardner et al., 1971). Primary BKPyV infection occurs early during
childhood and BKPyV thereafter persists in the renourinary tract
(Chesters et al., 1983; Knowles, 2006). Several independent studies
have demonstrated that BKPyV frequently reactivates and is asymp-
tomatically shed in the urine of immunocompetent individuals at
low viral loads of o5 log10 genome equivalents (GEq) per ml (Eglill rights reserved.
logy and Infection Control,
-9038 Tromsø, Norway.
naldo).
oup, Department of Medical
msø, Tromsø, Norway.
ork.et al., 2009; Kling et al., 2012; Polo et al., 2004). In patients with an
altered immune function, BKPyV shedding is more frequently
observed and the corresponding urine BKPyV loads typically exceed
7 log10 GEq/ml (for review, see Hirsch, 2010). Despite the wide-
spread reactivation of BKPyV replication, signiﬁcant pathology is
largely limited to kidney and bone marrow transplant recipients
presenting with polyomavirus-associated nephropathy (PyVAN) and
polyomavirus-associated hemorrhagic cystitis (PyVHC), respectively
(Dropulic and Jones, 2008; Hirsch, 2010; Hirsch and Steiger, 2003).
The pathogenesis of PyVAN is characterized by high-level BKPyV
replication in renal tubular epithelial cells of the transplant leading
to cytopathic loss and denudation of the epithelial monolayer in the
allograft tubulus. This is followed by leakage of virus into the tissue
and blood stream, inﬂammatory inﬁltrates in the interstitium,
tubulitis, and exhaustion of tubular epithelial cell regeneration
leading to tubular atrophy and interstitial ﬁbrosis (Hirsch, 2010;
Hirsch and Randhawa, 2009). Clinically, patients are characterized
by high-level viruria, decoy cell shedding and progression to viremia
and histologically proven disease (Hirsch et al., 2002). Mathematical
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recipients supports the view that BKPyV replication in PyVAN starts
in renal tubular epithelial cells and is then carried to the urothelial
cell compartment where more than 90% of urine BKPyV loads are
generated locally (Funk et al., 2008). Interestingly this high viral
replication is not associated with any direct pathology or symptoms
from the bladder despite histopathology data demonstrating exten-
sively infected urothelial cell layers (Nickeleit et al., 1999). However,
reﬂux from the ureteric compartment into the renal pyelon, distal
tubulus and medulla has been identiﬁed to be an important
parameter for disease progression (Funk et al., 2008). Urothelial
cells may therefore play a more important role in the development
of PyVAN than commonly realized.
In contrast to PyVAN, the pathogenesis of PyVHC is less well
understood. Even though more than 50% of allogenic bone
marrow transplant recipients have urine BKPyV loads of 47
log10 GEq/ml, symptomatic PyVHC is only seen in 5–15% (Arthur
et al., 1986; Bedi et al., 1995; Dropulic and Jones, 2008; Giraud
et al., 2006; Hirsch, 2010; Leung et al., 2001). PyVHC has been
suggested to result from a sequence of events (Azzi et al., 1999;
Binet et al., 2000). First, the bladder mucosa is subclinically
injured by the conditioning protocols used prior to bone marrow
transplantation. Then, during the aplastic phase, immunologically
uncontrolled high-level BKPyV replication in urothelial cells
causes denudation of the damaged bladder mucosa and thereby
inﬂammation which is enhanced upon engraftment of the allo-
geneic stem cell graft.
Despite the evidence that urothelial cells seem to play cardinal
roles in the pathogenesis of the major BKPyV diseases, only a few
studies have investigated BKPyV replication in urothelial cells.
Cells were isolated from urine of newborn infants and infected by
BKPyV. Immunoﬂuorescence staining 9 days post-infection
revealed cells expressing BKPyV early and late proteins
(Beckmann and Shah, 1983) and 3 weeks post-infection plaque
formation was reported (Sack et al., 1980). In both studies the
cells used were probably a mixture of cells exfoliated from the
renal tubules and pelvis, ureter, bladder and urethra (Felix et al.,
1980). The aim of this study was to characterize the replication of
BKPyV in primary bladder urothelial cells and compare it to the
characterized BKPyV replication in primary renal tubular epithe-
lial cells.Results
BKPyV infection in HUCs
To study BKPyV infection in HUCs, cells were ﬁrst exposed to
three 100-fold serial dilutions of gradient puriﬁed BKPyV with
viral loads of 1109, 1107 and 1105 GEq/ml, respectively.
Next immunoﬂuorescence staining with antibodies directed
against BKPyV early and late proteins was performed. At 96 hpi,
large T-antigen (LT-ag) and agnoprotein-expressing cells were
found in all infected wells (Fig. 1A, upper panel). Based on these
results, the corresponding infectious units were estimated as 200,
2, and 0.02 ﬂuorescence-forming units (FFU)/cell, respectively
(see Materials and methods). Compared to mock-infected cells,
the infected cells were increased in size, with enlarged nuclei and
cytoplasms. An inoculum of 2 FFU/cell resulted in 80–90%
infected cells, while 0.02 FFU/cell resulted in less than 5% infected
cells (Fig. 1A, upper panel). In wells with infected cells, particu-
larly when using the highest viral inoculum (200 FFU/cell), large
denuded areas were noted in the monolayer (Fig. 1A, upper
panel), and numerous detached HUCs were ﬂoating in the cell
culture supernatant prior to ﬁxing (not shown).Next, the time course of BKPyV infection in HUCs was
examined. Using 2 FFU/cell, LT-ag expression increased from
48 hpi onwards (Fig. 1A, lower panel). At 72 hpi, signiﬁcant
LT-ag and agnoprotein expression was seen. Denuded areas in
the HUC culture became prominent by 120 hpi (Fig. 1A, lower
panel). Using varying FFU/cell, it also became apparent that the
size of the viral inoculum inﬂuenced not only the number of
infected cells, but also the timing of BKPyV early and late protein
expression. Thus, at 48 hpi, cells infected with 0.02 FFU/cell only
expressed the early LT-ag, while cells infected with the higher
inoculum of 200 FFU/cell already expressed the late agnoprotein
(data not shown). In summary, increasing the viral inoculum
appeared not only to increase the number of infected cells, but
also to shorten the BKPyV life cycle in HUCs, and increase the
cytopathic loss.
To investigate the effect of BKPyV infection on HUCs in more
detail, real-time cell proliferation was measured from seeding
24 h before infection (i.e.24 hpi) up to 96 hpi using the xCelli-
gence system. Mock-infected HUCs showed a small consistent
increase of the cell index in the ﬁrst 48 h after seeding and
stabilized at a plateau over the next 48 h (Fig. 1B, blue line). By
contrast, BKPyV-infected HUCs demonstrated an increased cell
index after infection suggesting that BKPyV infection increases
cell division, cell size, initial attachment or a combination thereof
(Fig. 1B). The increase in cell index was higher and plateaued later
with 2 FFU/cell compared to the 0.02 FFU/cell inoculum (Fig. 1B,
compare green and red line). Of note, the largest viral inoculum of
200 FFU/cell caused a dramatic increase and then a rapid decline
in real-time cell index (Fig. 1B, purple line). Hence, the data
provided independent evidence for an inoculum-dependent virus-
mediated disruption of the HUC monolayer seen by microscopy.
By performing time-lapse microscopy on HUCs infected by 2 FFU/
cell, we were able to see many cells rounding up and detaching
from the monolayer without lysing (Video showing 62–93 hpi).
While some areas became denuded, detached decoy-like cells
were accumulating in the well. Though we cannot be entirely sure
that the detaching cells were infected, several ﬁndings support
this. First, extensive detachment was not seen in uninfected HUCs
(data not shown), second, as shown in Fig. 1A, the majority of cells
were infected when an inoculum of 2 FFU/cell was used and
ﬁnally the detaching cells had enlarged nuclei, which is typical for
infected cells.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.virol.2013.01.024.
Overall, the results indicate that HUCs are easily infected
by BKPyV and that the viral lifecycle and the ensuing
cytopathic effect is intensiﬁed by increasing the size of the BKPyV
inoculum.
Expression of BKPyV early and late proteins in HUCs
To study the expression of BKPyV proteins over time, HUCs
were infected with 2 FFU/cell and cell extracts were harvested for
western blot analysis at different times post-infection. Expression
of the viral early proteins LT-ag (80 kDa) and small T-ag (sT-ag)
(20 kDa) was detectable from 24 hpi onwards (Fig. 2). Also
expression of smaller T-ag proteins was detected. These corre-
spond to the truncated protein truncT-ag (17 kDa), expressed
from alternatively spliced early mRNA (Abend et al., 2009).
TruncT-ag was barely visible at 36 and 48 hpi, but became
stronger at 72 and 96 hpi. Trace amounts of VP1 (40 kDa)
corresponding to the input virus were seen at 12 and 24 hpi.
From 36 hpi onwards, VP1 expression became increasingly domi-
nant. Expression of VP2 (38 kDa) and VP3 (27 kDa) was ﬁrst
detected at 72 hpi. Similar to VP1, agnoprotein expression
(7 kDa) was ﬁrst found at 36 hpi. At 72 and 96 hpi, all major
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Fig. 1. Infection of HUCs with BKPyV. HUCs were mock-infected or infected with different dilutions of gradient puriﬁed BKPyV. (A) The upper panel shows mock-infected
cells and cells infected by 0.02, 2 and 200 FFU/cell and ﬁxed at 96 hpi while the lower panel shows cells infected by 2 FFU/cell and ﬁxed at 24, 48, 72 or 120 hpi. Note that
for 2 FFU/cell the 96 hpi time point is shown in the upper panel. After ﬁxation immunoﬂuorescence staining with a combination of a mouse monoclonal antibody directed
against SV40 LT-ag but cross-reacting with BKPyV LT-ag (red, Alexa 568) and polyclonal rabbit serum directed against agnoprotein (green, Alexa 488) was performed. DNA
(nucleus) was stained by Draq5 (blue). Images were acquired using a standard ﬂuorescence microscope and are overlay of phase contrast and ﬂuorescence channels.
(B) Mock-infected and infected cells were observed with the xCelligence system from cell seeding 24 h before infection (i.e.24 hpi) and until 96 hpi. Results are presented
as cell index normalized at 1 h before infection. The experiment was repeated twice and showed corresponding results. (For interpretation of the references to color in this
ﬁgure caption, the reader is referred to the web version of this article.)
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Fig. 2. Early and late BKPyV protein expression. HUCs were infected with BKPyV,
harvested for generation of whole cell extracts at 12, 24, 48, 72, 96 and 120 hpi
and subjected to denaturing PAGE. Western blot was performed with a combina-
tion of polyclonal rabbit sera directed against VP1, SV40 VP2 and VP3 (known to
crossreact with BKPyV VP2 and VP3), agnoprotein, the N-terminal part of LT-ag
(recognizing LT-ag and st-ag), respectively, and mouse monoclonal antibodies
directed against SV40 LT-ag (here only used to demonstrate truncT) and the house
keeping protein GAPDH. Mock-infected HUCs, harvested at a time corresponding
to 72 hpi, were used as a negative control. The membrane exposure time of TruncT
was extended because of its weak expression. The experiment was repeated twice
and showed corresponding results.
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sion decreased towards 120 hpi. This decrease corresponded with
the observed loss of cells from the monolayer and was paralleled
by decreased GAPDH detection. We conclude that all known
BKPyV proteins were expressed in HUCs as previously observed
in BKPyV-infected RPTECs (Bernhoff et al., 2008;Sharma et al.,
2011).
Comparing BKPyV replication and release of infectious progeny in
HUCs and RPTECs
To directly compare BKPyV replication in HUCs and RPTECs,
primary cell cultures of both were infected with the same amount
of virus (2 FFU/cell in HUCs) and supernatants were harvested
every 24 h up to 120 hpi. Immunoﬂuorescence staining at 72 hpi
showed about the same number of agnoprotein-expressing cells
per well in HUCs compared to RPTECs (Fig. 3A). However, the
ratio of infected cells (expressing agnoprotein) to uninfected cells
was higher for HUCs than for RPTECs. As shown previously, all
agnoprotein-expressing cells also expressed LT-ag. In addition,
many RPTECs only showed LT-ag expression suggesting that a
second replication cycle had started.
Since an increase in extracellular BKPyV DNA load from
BKPyV-infected RPTECs is known to correspond with release of
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Fig. 3. Expression of BKPyV early and late proteins, extracellular BKPyV load and infectious progeny from HUCs and RPTECs. About 15,000 HUCs/well and 12,500 RPTECs/
well (allowing for faster cell growth) were seeded and 24 h later infected with the same amount of virus, approximately 2 FFU/cell. (A) At 72 hpi immunoﬂuorescence
staining with a combination of a mouse monoclonal antibody directed against SV40 LT-ag (red, Alexa 568) and polyclonal rabbit serum directed against agnoprotein
(green, Alexa 488) was performed. DNA (nucleus) was stained by Draq5 (blue). The images were acquired using a standard ﬂuorescence microscope and are overlay of all
ﬂuorescence channels. A representative result of two independent experiments is shown. (B) Cell free supernatants harvested at 24, 48, 72, 96 and 120 hpi were measured
for extracellular BKPyV DNA by qPCR. The results are presented as BKPyV GEq/ml. The values represent the mean of two experiments. The error bars represent the SD and
the asterisk denotes a p-valueo0.05 as determined by the t-test. (C) Cell free supernatants harvested at 24, 48, 72, 96 and 120 hpi were diluted 1:2 and used to infect
RPTECs. The cells were ﬁxed at 72 hpi and stained with a combination of mouse monoclonal antibody directed against SV40 LT-ag (red, Alexa 568) and polyclonal rabbit
serum directed against agnoprotein (green, Alexa 488). DNA was stained by Draq5 (blue). The images were acquired using a standard ﬂuorescence microscope and are
overlays of all ﬂuorescence channels. Cells infected with supernatants harvested at 24 hpi showed no expression of BKPyV proteins and therefore no photos are shown. A
representative result of two independent experiments is shown. (For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version
of this article.)
R. Li et al. / Virology 440 (2013) 41–5044infectious BKPyV (Rinaldo et al., 2010; Sharma et al., 2011) a qPCR
was performed on the harvested supernatants. For HUCs, no
signiﬁcant increase from the residual input viral load was
observed until 72 hpi when an increase of 2 log10 GEq/ml was
noted (Fig. 3B). Over the next 48 h, a further increase of 0.8 log10
GEq/ml was found. By contrast, supernatants from RPTECs
demonstrated an increase in BKPyV load of almost 3 log10 GEq/
ml as early as 48 hpi. Until 120 hpi, a further increase of 0.9 log10
GEq/ml was seen. From 48 until 120 hpi, the BKPyV DNA load wasalways between 1.0 and 2.6 log10 GEq/ml higher in supernatants
from RPTECs compared to supernatant from HUCs.
In order to study whether or not the extracellular BKPyV loads
from HUCs corresponded with infectious progeny, supernatants
from BKPyV-infected HUCs were added to freshly seeded RPTECs as
indicator cells and analyzed by immunoﬂuorescence staining at
72 hpi. Supernatants from HUCs harvested at 24 and 48 hpi did not
result in infection of indicator cells, suggesting that these super-
natants did not contain detectable amounts of infectious BKPyV
R. Li et al. / Virology 440 (2013) 41–50 45(Fig. 3C). However, when supernatants harvested at 72, 96 and
120 hpi were used, infectious activity could be detected as indi-
cated by LT-ag and agnoprotein expression (Fig. 3C). By contrast, all
RPTEC supernatants harvested from 48 to 120 hpi contained
infectious BKPyV (Fig. 3C). We conclude that HUCs are very
susceptible to infection by BKPyV, but that the release of infectious
progeny appears to be reduced and delayed compared to RPTECs.
Inﬂuence of BKPyV infection on cell viability
The denudation of the HUC monolayer and the delayed release
of infectious progeny suggested that BKPyV infection of HUCs was
causing an infectious dose-dependent cell detachment rather than
host cell lysis as observed for BKPyV-infected RPTECs. To address
the difference in host cell lysis, we compared cytokeratin (CK)-18
release from BKPyV-infected HUCs and RPTECs. Levels of CK-18
were measured in supernatants from mock-infected and BKPyV-
infected HUCs and RPTECs up to 120 hpi (Fig. 4A). No signiﬁcant
difference was found between mock-infected and infected HUCs
until 72 hpi. At 96 and 120 hpi however, a 1.6- and 3-fold increaseHours postinfection
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Fig. 4. Viability of mock-infected and BKPyV-infected HUCs and RPTECs. About 15,000
infected with the same amount of virus, approximately 2 FFU/cell. (A) Supernatants wer
with the M65 ELISA. To obtain a positive control for cell death, staurosporine at 0.1 mMw
and represent the mean of two experiments. The error bars represent the SD and the ast
BKPyV-infected HUCs. Right: mock-infected and BKPyV-infected RPTECs. (B) At 72 hpi
with a combination of primary antibodies directed against CK-18 (red, Alexa 568) and
images were acquired using a confocal ﬂuorescence microscope. (For interpretation of th
of this article.)in CK-18 release was detected in supernatants from BKPyV-
infected HUCs, respectively, compared to mock-infected HUCs
(Fig. 4A). To measure CK-18 release independent of viral infection,
we used staurosporine as a well known cell death inducer (Dunai
et al., 2012). Staurosporine was added at 0.1 mM to uninfected
HUCs and supernatants harvested 20 h later (corresponding to
72 hpi), when practically all cells were found to be dead by
microscopy. Compared to mock-infected HUCs a 5.8-fold increase
in CK-18 level was detected (Fig. 4A). Supernatants from mock-
infected RPTECs were found to contain a baseline CK-18 level up to
50-fold higher than supernatants from mock-infected HUCs which
did not change signiﬁcantly during the observation time of 120 hpi.
Supernatants of BKPyV-infected RPTECs, however, showed a 1.8-
fold increase of CK-18 by 48 hpi and 4- to 5-fold increase from 72
to 120 hpi over that observed in supernatants from mock-infected
RPTECs (Fig. 4A). Addition of staurosporine at 0.1 mM for 20 h killed
all cells as judged by microscopy and increased the CK-18 level by
5.4-fold compared to mock-infected RPTECs at 72 hpi (Fig. 4A).
Given the higher baseline level of CK-18 in supernatants from
RPTECs compared to HUCs, both cell types were compared byOverlay
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HUCs/well and 12,500 RPTECs/well were seeded and 24 h later mock-infected or
e harvested at 24, 48, 72, 96 and 120 hpi, made cell free and CK-18 levels measured
as added to uninfected cells for 20 h. Results are presented as CK-18 release in U/L
erisk denotes a p-valueo0.05 as determined by the t-test. Left: mock-infected and
immunoﬂuorescence staining of BKPyV infected HUCs and RPTECs was performed
agnoprotein (green, Alexa 488). DNA (nucleus) was stained by Draq5 (blue). The
e references to color in this ﬁgure caption, the reader is referred to the web version
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CK-18 in RPTECs than in HUCs (Fig. 4B). Overall the data indicated
that BKPyV infection induces cell lysis in both HUCs and RPTECs
but cell lysis seems to occur signiﬁcantly later in BKPyV-infected
HUCs than in RPTECs. In addition, the results suggest that unlike
for RPTECs, denudation of BKPyV-infected HUCs monolayers initi-
ally involves detachment of morphologically altered BKPyV-
infected, but still intact HUCs.
Nuclear architecture and ultrastructural features of BKPyV-infected
HUCs
We have previously reported that BKPyV-infected RPTECs may
contain large nuclear inclusions with strong VP1 signals sur-
rounded by LT-ag staining (Bernhoff et al., 2010; Sharma et al.,
2011). To investigate the nuclear architecture of BKPyV-infected
HUCs, immunoﬂuorescence staining for LT-ag and VP1 was
performed at 72 hpi and followed by confocal microscopy. While
some HUCs demonstrated large nuclear inclusions, other cells
showed a more homogenous VP1 staining of the nucleus (Fig. 5).
The presence of BKPyV-infected cells with large nuclear inclusion
side-by-side with nuclei showing more homogenous VP1-staining
has been observed previously in cultures of BKPyV infected
RPTECs (Rinaldo et al., 2010), and is probably related to different
stages of the viral lifecycle.
To further characterize BKPyV-infection in HUCs, electron
microscopy was used (Fig. 6). Both infected and mock-infected
HUCs exhibited ultrastructual features similar to what has been
observed for organ cultures from normal bladder urothelium
(Knowles et al., 1983) and biopsies from normal bladder urothe-
lium (Jost et al., 1989). The cytoplasm contained large amounts of
rough endoplasmic reticulum (A) and microvilli were seen (B). At
24 hpi, no virus could be detected in the cells but from 48 hpi
nuclear clusters of virus were found in a small proportion of HUCs
(data not shown). At 72 hpi, more cells contained nuclear cluster
of virus (C). Some viral particles were found in close proximity to
the nuclear pores (data not shown), and occasionally small
clusters of virus were detected in the cytoplasm or on the plasma
membrane (D). From 72 to 96 hpi, some infected cells exhibited
cell death features most likely to be necrosis (E). Organelles
started to degrade and the cytoplasm became more or less
homogenous while the nucleus remained fairly intact. We con-
clude that infected HUCs are characterized by large nuclear
inclusions containing extensive amounts of viral particles.Discussion
High-level replication of BKPyV in urothelial cells is a common
feature of PyVHC and PyVAN, but the clinical presentation in theVP1 LT-ag
Fig. 5. Nuclear architecture of BKPyV infected HUCs. Following BKPyV infection of HUCs
primary antibodies directed against SV40 LT-ag (red, Alexa 568) and VP1 (green, Alexa
acquired using a confocal ﬂuorescence microscope. (For interpretation of the referenc
article.)urothelial compartment is dramatically different. Although in
both entities, urine BKPyV loads of 7–10 log10 GEq/ml have been
reported, only PvVHC is associated with signiﬁcant inﬂammation,
pain, and hematuria leading to anemia and urinary obstruction
due to bloodclots which sometimes leads to post-renal failure (for
review, see Hirsch, 2010). Replication of BKPyV in renal tubular
epithelial cells in vitro was initially characterized by Low et al.
(2004). In this study, we present the ﬁrst detailed characterization
of HUCs as host cells for BKPyV infection. The results show that
HUCs are very permissive to BKPyV. Almost every cell is infected
when an appropriately sized viral inoculum is used. However,
compared to BKPyV-infection of RPTECs, the BKPyV life cycle
seems delayed and less viral progeny is released. The most
striking difference between BKPyV replication in HUCs and
RPTECs is that BKPyV-infection induces a pronounced cytopatho-
genic effect resulting in signiﬁcant detachment of HUCs from the
monolayer. Our results show that the disruption of the HUC
monolayer is not caused by cell lysis as observed in BKPyV-
infected RPTECs. Instead, the cells were detached and seemed
to be more or less intact until 96 hpi, when CK-18 levels in
supernatants started to increase to approximately 3-fold at
120 hpi. Thus the remaining attached BKPyV-infected HUCs
eventually appear to also undergo cell lysis. This is supported
by the EM results showing a necrosis-like form of cytopathology
in attached cells. In contrast to HUCs, RPTECs seem to replicate
BKPyV somewhat faster with earlier cell lysis and virus release as
evidenced by the increased BKPyV DNA load, early release of
infectious progeny and CK-18 to supernatants, and signs of early
reinfection.
For the infection of HUCs, we tested a wide range of BKPyV
inoculums ranging from 5 to 9 log10 GEq/ml similar to urine
BKPyV loads frequently found in patients with PyVAN or PyVHC
(Hirsch and Randhawa, 2009, 2013). Interestingly, the ratio of
infected to uninfected cells was clearly higher in HUCs than
RPTECs. Since infection with BKPyV is suspected to prevent cell
division by inducing a G2 arrest as previously described for JCPyV
(Orba et al., 2010) and recently also for BKPyV (Jiang et al., 2012)
we expect that only uninfected cells continue to proliferate.
According to our results from the real-time proliferation system
XCelligence and microscopy, mock-infected HUCs proliferate
more slowly than mock-infected RPTECs which possibly could
explain the different ratios observed. While the cell index for
mock-infected HUCs increased less than 2-fold from the time of
cell seeding and during the next 96 h (Fig. 1B), it increased by 5.5-
fold during the same time span in mock-infected RPTECs (Sharma
et al., 2011). The slow proliferation of HUCs is not surprising since
the urothelium is known to be one of the slowest cycling epithelia
in the body, with a turnover rate of about 200 days (Wu et al.,
2009). Once infected with BKPyV, the cell index showed an
increase over the mock-infected baseline. A similar increase wasOverlay
50 µm
, cells were ﬁxed at 72 hpi and immunoﬂuorescence staining with a combination of
488) was performed. DNA (nucleus) was stained by Draq5 (blue). The images were
es to color in this ﬁgure caption, the reader is referred to the web version of this
Fig. 6. Electron microscopy (EM) of mock-infected and BKPyV-infected HUCs. Mock-infected (A) and BKPyV-infected HUCs (B–E) were ﬁxed at different times (as indicated
below) and were prepared for conventional transmission EM. Cell nucleus is labeled with n. (A) Mock-infected HUC 48 h post-seeding (corresponding to 24 hpi) containing
large amounts of rough endoplasmic reticulum (¼ER). (B) HUC 48 hpi with microvilli (¼m). Here no virus particles were visualized by conventional transmission EM.
(C) HUC 72 hpi, with big clusters of viral particles in the nucleus. The inset shows the viral particles in higher magniﬁcation. (D) HUC 96 hpi with virus lining the plasma
membrane. (E) Necrotic BKPyV-infected cell at 96 hpi. The organelles have started to degrade and the cytoplasm is more or less homogenous while the nucleus is fairly
intact.
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2011). A high BKPyV inoculum dramatically increased HUCs size
and possibly transiently also attachment before cells eventually
started detaching causing signiﬁcant disruption of the cell-layer.
The western blot results with cell extracts from HUCs infected
with about 2 FFU/cell, suggested that early and late BKPyV
proteins were expressed in a time course similar to what we
and others previously have observed during infection of RPTECs
(Bernhoff et al., 2008; Low et al., 2004). The immunoﬂuorescence
staining of cells infected with different viral inoculums revealedthat the infection proceeds more rapidly when started with
higher than lower viral inoculums. This phenomenon has been
described earlier for SV40 (Cole, 1996), and may be explained by a
critical threshold level of BKPyV early proteins which is obtained
earlier when more BKPyV DNA is available for transcription.
Similar to our earlier ﬁndings in RPTECs (Bernhoff et al., 2010;
Sharma et al., 2011), HUCs with nuclear inclusions and large
amounts of BKPyV in their nuclei were found at 72 hpi. The
release of infectious progeny, however, seemed to start between
48 and 72 hpi which is up to 1 day delayed compared to infection
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HUCs was highest 5 dpi but was then only at the same level as
extracellular BKPyV DNA load from RPTEC 2 dpi. This difference
cannot be fully explained by a delayed BKPyV replication cycle in
HUCs. Other explanations would be that HUCs produce less
virions than RPTECs or, more likely in the context of our earlier
discussed results, that less virus is released from HUCs.
Our in vitro ﬁnding of BKPyV-infected urothelial cells detach-
ing without lysis matches the observation of abundant ‘‘decoy
cells’’ in urines of kidney transplant recipients with high-level
BKPyV replication and urine viral loads above 7 log10 GEq/ml. Of
note the ﬁnding of decoy cells triggered the original isolation of
BKPyV (Gardner et al., 1971). In addition, detachment instead of
local cell lysis may explain the absence of signiﬁcant inﬂamma-
tion despite the presence of high-level BKPyV replication in the
urothelial cells compartment as discussed previously (Hirsch and
Steiger, 2003). It also suggests that high-level BKPyV replication
may be a signiﬁcant factor leading to denudation of the urothelia
pre-damaged by the conditioning protocols in bone marrow
transplant recipients. Thus, BKPyV-mediated denudation, uro-
toxic conditioning, and allogenic immune reconstitution post-
engraftment become synergistic factors in PyVHC pathogenesis
(Hirsch, 2010). By reducing the impact of BKPyV replication,
antiviral therapy with drugs like the lipid-conjugate of cidofovir
CMX001 (Rinaldo et al., 2010) might have the potential to prevent
the onset of PyVHC when given prophylactically, or enhance
urothelial recovery when given therapeutically. Testing this drug
in HUCs is currently underway.
In conclusion we found that HUCs are very amenable to
infection by BKPyV, but the replication cycle of BKPyV is slower
than in RPTECs and less progeny virus is released since HUCs
detach without lysing. Our ﬁndings expand our understanding on
how the ubiquitous BKPyV can quietly coexist and provide
testable hypotheses on how BKPyV replication can cause severe
disease in its human host.Material and methods
Cells, virus and infection
Primary human urothelial cells (HUCs) (Cat. no. 4320) and
renal proximal tubular epithelial cells (RPTECs) (Cat. no. 4100)
were purchased from ScienCell Research Laboratories (http://
www.sciencellonline.com/) and propagated as described by the
manufacturer except that the RPTECs were grown in Renal
Epithelial Cell Growth Medium (Lonza, www.lonzabio.com) con-
taining 0.5% FBS. No latent or productive BKPyV infection could be
detected by PCR of DNA from HUCs or RPTECs prior to in vitro
BKPyV infection. All experiments were performed with cells at
passage 4. HUCs from two different donors were used with
similar results. HUCs were seeded on poly-L-lysine coated plates,
except for experiments with real-time cell status monitoring
which were performed in ﬁbronectin coated wells. RPTECs were
seeded in uncoated wells. One day after seeding, BKPyV-Dunlop
supernatants or gradient puriﬁed virus, both obtained from Vero
cells, were used to infect the cells for 2 h before washing away the
viral inoculums and adding of growth medium. The number of
ﬂuorescence forming units per ml (FFU/ml) of puriﬁed virus was
determined by infecting HUCs with 0.1 ml of diluted puriﬁed
virus as described above followed by immunostaining for BKPyV
agnoprotein (Rinaldo et al., 1998) 4 days post-infection and
counting of ﬂuorescent cells per well. The FFU/cell was found by
dividing the number of FFU used to infect one well with the
estimated cell number in that well at the time of infection.Immunoﬂuorescence staining, microscopy and digital image
processing
Immunoﬂuorescence staining was performed as previously
described (Rinaldo et al., 2010). Primary antibodies used were
mouse monoclonal anti-simian virus 40 (SV40) LT-ag (Pab416;
1:100) (http://www.abcam.com/), anti-human cytokeratin 18
(Clone DC 10 1:400) (http://www.dako.com/) and polyclonal
rabbit antiserum directed against agnoprotein (1:1200) or VP1
(1:1200) (Bernhoff et al., 2008; Hey et al., 1994). Images were
collected using a Nikon TE2000 microscope and processed with
NIS-Elements BR 3.2 (Nikon Corporation) or using a Zeiss Axiovert
200 confocal microcope equipped with an LSM510-META confocal
module using the LSM5 software version 3.2 (Carl Zeiss).
Real-time cell status monitoring
Cell adhesion, proliferation and size of mock-infected and
BKPyV-infected HUCs were monitored in real-time by the use of
the xCELLigence RTCA DP instrument (Roche, www.roche-ap
plied-science.com) measuring electric impedance as previously
described in more details for RPTECs (Rinaldo et al., 2010). The
electric impedance was expressed as a cell index (CI). In short,
24 h after seeding, half of the media was replaced with fresh
media with or without puriﬁed BKPyV-Dunlop at different dilu-
tions. The CI was measured every 15 min for the ﬁrst 6 h after
seeding and thereafter every 30 min until 96 h post-infection
(hpi) when the experiments were stopped due to a combination
of nutrient exhaustion and evaporation.
Time-lapse microscopy
To image mock-infected and BKPyV infected HUCs over time
the Nikon Biostation IM was used. The biostation is a small
incubation unit equipped with a microscope and camera. The
cells were seeded in poly-L-lysine coated Hi-Q4 culture dishes
(Nikon, www.interinst.no). One day after seeding, infection was
performed for 2 h before medium or viral inoculum was replaced
by fresh medium and culture dishes were transferred to the
biostation. The cells were photographed every 10 min from
3 hpi to 120 hpi using a 10 objective (Nikon).
Western Blotting
Cells were lysed in cell disruption buffer (mirVanaTM miRNA
isolation kit, Ambion), collected and stored at 70 1C. One
quarter of the cell lysate generated from one 48-well was loaded
and proteins were separated by denaturing electrophoresis on a
4–12% NuPage bis–tris gel (Invitrogen, http://www.invitrogen.
com) and transferred onto a PVDF membrane. Viral and cellular
proteins were detected by a combination of polyclonal rabbit
antiserum against BKPyV N-terminal LT-ag (1:2000) (Sharma
et al., 2011), VP1(1:10,000) (Rinaldo et al., 2003), agnoprotein
(1:10,000) (Hey et al., 1994; Rinaldo et al., 1998) and SV40 VP2
and VP3 (ab53983; 1:5000, Abcam) and mouse monoclonal anti-
body against SV40 LT-ag (Pab416; 1:500, Abcam) and GAPDH
(6C5; 1:5000, Abcam) as previously described (Rinaldo et al.,
2010). The protein standard marker was Odyssey Two color
marker (Li-cor, http://www.licor.com/).
Extracellular BKPyV DNA load
Cell culture supernatants of infected cells were harvested
every 24 h until 120 hpi, purged of cells and debris by centrifuga-
tion at 200 g for 5 min and frozen at 70 1C. BKPyV DNA loads
were determined by quantitative PCR (qPCR) targeting BKPyV
R. Li et al. / Virology 440 (2013) 41–50 49LT-ag gene (Hirsch et al., 2001) after the cell culture supernatants
were diluted in dH2O (1:100) and boiled for 5 min. Each sample
was analyzed in triplicate.Release of infectious progeny
Release of infectious progeny into the supernatant was
detected by the use of RPTECs as previously described (Rinaldo
et al., 2010; Sharma et al., 2011). In short, cell culture super-
natants harvested from BKPyV-infected HUCs and RPTECs at
24–120 hpi were diluted 1:2 in growth medium and added to
RPTECs for 2 h followed by removing the supernatants, washing
and adding fresh growth medium. At 3 dpi, the cells were washed,
methanol ﬁxed and immunostained as described above.Cytokeratin-18 cell death assay
Overall cell death (necrosis and apoptosis) was measured by
the use of the M65 ELISA (PEVIVA, www.peviva.se). This assay
detects epitopes present in the full-length cytokeratin-18 (CK-18)
protein and in the caspase-cleaved CK-18 fragment generated
during apoptosis, which can be detected in the supernatant
following cell lysis. Cell culture supernatants from mock-
infected and BKPyV-infected HUCs and RPTECs were harvested
at 24–120 hpi, freed from cells and debris by centrifugation at
200 g for 5 min and frozen at 70 1C until the assay was
performed according to the manufacturer’s protocol. Staurospor-
ine (Sigma-Aldrich, www.sigmaaldric.com) at 0.1 mM was used
for 20 h to induce cell death as a positive control.Electron microscopy
HUCs were washed in ice-cold PBS and ﬁxed in 4% formalde-
hyde in 200 mM HEPES buffer (pH 7.5) overnight. The cells were
scraped off and concentrated by centrifugation and prepared for
conventional transmission microscopy by further ﬁxation in
McDowell and Trump ﬁxative (McDowell and Trump, 1976). All
sections were examined in a JEOL JEM 1010 transmission electron
microscope (JEOL, Tokyo, Japan) operating at 80 kV.Statistical analysis
When appropriate, mean and standard derivation (SD) were
calculated and P-values determined by the use of the unpaired t-
test (GraphPad, http://www.graphpad.com).Acknowledgment
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